Vincerx Pharma (NASDAQ: VINC) Modifies Terms of Business Combination with Oqory

Vincerx Pharma, Inc. recently disclosed in an 8-K filing an update on a binding term sheet with Oqory, Inc., a Delaware corporation, concerning a proposed business merger. The original agreement detailed that Oqory’s equity holders would possess 95% of the combined company’s equity, with Vincerx Pharma’s equity holders retaining 5%. Furthermore, in a scenario where […]

Leave a Reply

Your email address will not be published.

Previous post Vor Biopharma (NYSE:VOR) Announces Stock Option Repricing
Next post Burns Matteson Capital Management LLC Makes New $61,000 Investment in ACCO Brands Co. (NYSE:ACCO)